TFOAX
Price
$79.68
Change
+$0.73 (+0.92%)
Updated
Aug 8 closing price
Net Assets
1.37B
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

TFOAX vs VSTSX

Header iconTFOAX vs VSTSX Comparison
Open Charts TFOAX vs VSTSXBanner chart's image
Touchstone Focused A
Price$79.68
Change+$0.73 (+0.92%)
VolumeN/A
Net Assets1.37B
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
TFOAX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TFOAX vs. VSTSX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFOAX is a Buy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. TFOAX (1.37B). VSTSX pays higher dividends than TFOAX: VSTSX (1.20) vs TFOAX (0.31). TFOAX was incepted earlier than VSTSX: TFOAX (22 years) vs VSTSX (9 years). TFOAX (1.19) is less costly to investors than VSTSX (0.01). TFOAX is a more actively managed with annual turnover of: 5.00 vs. VSTSX (2.00). TFOAX has a lower initial minimum investment than VSTSX: TFOAX (2500) vs VSTSX (5000000000). VSTSX (19.70) and TFOAX (18.86) have marching annual gain over last year. VSTSX return over 5 years is better than : 85.11 vs. TFOAX (66.08).
TFOAXVSTSXTFOAX / VSTSX
Total Expense Ratio1.190.0111,900%
Annual Report Gross Expense Ratio1.190.0111,900%
Fund Existence22 years9 years-
Gain YTD9.1068.088113%
Front Load5%N/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B1.91T0%
Annual Yield % from dividends0.311.2026%
Returns for 1 year18.8619.7096%
Returns for 3 years46.0552.0588%
Returns for 5 years66.0885.1178%
Returns for 10 years109.14N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited